红鹰彩票软件,光大彩票登录官方平台,乐鱼官方网站在线登录网页,澳门网上真人注册,凤凰彩票手机,凤凰彩票注册,大小单双彩票app平台网站

On September 21, 36Kr Venture Capital Research Institute released its annual list for 2022. C&D Emerging Industry Equity Investment Co., Ltd. won the awards of “China’s Top20 Marketization Fund of Funds voted by General Partners” for the third consecutive year, “China’s Top10 Fund of Funds Direct Investment in Equity Investment Market” for the second consecutive year, and “China’s Top10 Secondary Fund in Equity Investment Market” for the first time.

In addition, the company participated in the Legend Xinhai Fund and the Eastern Bell Capital RMB Phase 5 Fund among the “China’s Home Market Top10 Best Return Fund”, and participated in three cases of CATL, Pharmaron and Bloomage BioTechnology among the “China’s Home Market Top10 Best Return Star Cases”.